Neonatal outcome following elective cesarean section of twin pregnancies beyond 35 weeks of gestation - 21/11/12
Résumé |
Objective |
We sought to assess neonatal morbidity and mortality of elective cesarean section (CS) of uncomplicated twin pregnancies per week of gestation >35+0.
Study Design |
We performed a retrospective cohort study in our nationwide database including all elective CS of twin pregnancies. Two main composite outcome measures were defined, ie, severe adverse neonatal outcome and mild neonatal morbidity.
Results |
We report on 2228 neonates. More than 17% were born <37+0 weeks of gestation. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for severe adverse neonatal outcome at 35+0-6, 36+0-6, and 37+0-6 weeks were, OR, 9.4; 95% CI, 3.2–27.6; OR, 1.7; 95% CI, 0.5–5.3; and OR, 0.7; 95% CI, 0.2–2.0, respectively; and for mild neonatal morbidity, OR, 4.7; 95% CI, 2.6–8.7; OR, 4.9; 95% CI, 3.1–7.9; and 1.4; 95% CI, 0.9–2.1, respectively, compared to neonates born ≥38+0 weeks of gestation.
Conclusion |
In uncomplicated twin pregnancies elective CS can best be performed between 37+0 and 39+6 weeks of gestation.
Le texte complet de cet article est disponible en PDF.Key words : cesarean section, neonatal morbidity, timing, twin
Plan
| The authors report no conflict of interest. |
|
| Reprints not available from the authors. |
|
| Cite this article as: Wilmink FA, Hukkelhoven CWPM, Mol BWJ, et al. Neonatal outcome following elective cesarean section of twin pregnancies beyond 35 weeks of gestation. Am J Obstet Gynecol 2012;207:480.e1-7. |
Vol 207 - N° 6
P. 480.e1-480.e7 - décembre 2012 Retour au numéro
Article précédent
- The association between hospital obstetric volume and perinatal outcomes in California
- Jonathan M. Snowden, Yvonne W. Cheng, Caitlin P. Kontgis, Aaron B. Caughey
- Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy
- Amanda M. Cotter, Kathleen F. Brookfield, Lunthita M. Duthely, Victor H. Gonzalez Quintero, JoNell E. Potter, Mary J. O'Sullivan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?